These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 22395975

  • 1. Vascular endothelial growth factor receptor 2 gene polymorphisms as predictors for tumor recurrence and overall survival in non-small-cell lung cancer.
    Uzunoglu FG, Kaufmann C, Wikman H, Güngör C, Bohn BA, Nentwich MF, Reeh M, Pantel K, Bockhorn M, Kutup A, Mann O, Izbicki JR, Vashist YK.
    Ann Surg Oncol; 2012 Jul; 19(7):2159-68. PubMed ID: 22395975
    [Abstract] [Full Text] [Related]

  • 2. C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC.
    Uzunoglu FG, Yavari N, Bohn BA, Nentwich MF, Reeh M, Pantel K, Perez D, Tsui TY, Bockhorn M, Mann O, Izbicki JR, Wikman H, Vashist YK.
    Lung Cancer; 2013 Jul; 81(1):123-9. PubMed ID: 23548249
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 genetic variants are associated with survival in unresectable locally advanced non-small cell lung cancer.
    Bi N, Yang M, Zhang L, Chen X, Ji W, Ou G, Lin D, Wang L.
    Clin Cancer Res; 2010 Apr 15; 16(8):2383-90. PubMed ID: 20332326
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in the FAS and FASL genes and survival of early stage non-small cell lung cancer.
    Park JY, Lee WK, Jung DK, Choi JE, Park TI, Lee EB, Cho S, Park JY, Cha SI, Kim CH, Kam S, Jung TH, Jheon S.
    Clin Cancer Res; 2009 Mar 01; 15(5):1794-800. PubMed ID: 19240174
    [Abstract] [Full Text] [Related]

  • 7. AKT1 polymorphisms and survival of early stage non-small cell lung cancer.
    Kim MJ, Kang HG, Lee SY, Jeon HS, Lee WK, Park JY, Lee EB, Lee JH, Cha SI, Kim DS, Kim CH, Kam S, Jung TH, Park JY.
    J Surg Oncol; 2012 Feb 01; 105(2):167-74. PubMed ID: 21842521
    [Abstract] [Full Text] [Related]

  • 8. A polymorphic -844T/C in FasL promoter predicts survival and relapse in non-small cell lung cancer.
    Sung WW, Wang YC, Cheng YW, Lee MC, Yeh KT, Wang L, Wang J, Chen CY, Lee H.
    Clin Cancer Res; 2011 Sep 15; 17(18):5991-9. PubMed ID: 21807637
    [Abstract] [Full Text] [Related]

  • 9. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
    Lee Y, Yoon KA, Joo J, Lee D, Bae K, Han JY, Lee JS.
    Carcinogenesis; 2013 Feb 15; 34(2):307-13. PubMed ID: 23144319
    [Abstract] [Full Text] [Related]

  • 10. Association of RASSF1A and p63 with poor recurrence-free survival in node-negative stage I-II non-small cell lung cancer.
    Ko E, Lee BB, Kim Y, Lee EJ, Cho EY, Han J, Shim YM, Park J, Kim DH.
    Clin Cancer Res; 2013 Mar 01; 19(5):1204-12. PubMed ID: 23319821
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients.
    Zhou W, Heist RS, Liu G, Neuberg DS, Asomaning K, Su L, Wain JC, Lynch TJ, Giovannucci E, Christiani DC.
    Cancer Epidemiol Biomarkers Prev; 2006 Nov 01; 15(11):2239-45. PubMed ID: 17119052
    [Abstract] [Full Text] [Related]

  • 12. Clinical significance of IGF1R expression in non-small-cell lung cancer.
    Nakagawa M, Uramoto H, Oka S, Chikaishi Y, Iwanami T, Shimokawa H, So T, Hanagiri T, Tanaka F.
    Clin Lung Cancer; 2012 Mar 01; 13(2):136-42. PubMed ID: 22133293
    [Abstract] [Full Text] [Related]

  • 13. The prognostic impact of microRNA sequence polymorphisms on the recurrence of patients with completely resected non-small cell lung cancer.
    Yoon KA, Yoon H, Park S, Jang HJ, Zo JI, Lee HS, Lee JS.
    J Thorac Cardiovasc Surg; 2012 Oct 01; 144(4):794-807. PubMed ID: 22818121
    [Abstract] [Full Text] [Related]

  • 14. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
    Kojima H, Shijubo N, Yamada G, Ichimiya S, Abe S, Satoh M, Sato N.
    Cancer; 2005 Oct 15; 104(8):1668-77. PubMed ID: 16116610
    [Abstract] [Full Text] [Related]

  • 15. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG, Chae YS, Sohn SK, Cho YY, Moon JH, Park JY, Jeon SW, Lee IT, Choi GS, Jun SH.
    Clin Cancer Res; 2008 Jan 01; 14(1):62-6. PubMed ID: 18172253
    [Abstract] [Full Text] [Related]

  • 16. Prognostic impact of the primary tumor location based on the hilar structures in non-small cell lung cancer with mediastinal lymph node metastasis.
    Ito M, Yamashita Y, Miyata Y, Ohara M, Tsutani Y, Ikeda T, Misumi K, Harada H, Omori K.
    Lung Cancer; 2012 Apr 01; 76(1):93-7. PubMed ID: 22285532
    [Abstract] [Full Text] [Related]

  • 17. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
    Bonnesen B, Pappot H, Holmstav J, Skov BG.
    Lung Cancer; 2009 Dec 01; 66(3):314-8. PubMed ID: 19324448
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma.
    Arinaga M, Noguchi T, Takeno S, Chujo M, Miura T, Uchida Y.
    Cancer; 2003 Jan 15; 97(2):457-64. PubMed ID: 12518370
    [Abstract] [Full Text] [Related]

  • 19. The prognostic significance of lymphovascular invasion on biopsy specimens in lung cancer treated with definitive chemoradiotherapy.
    Massabeau C, Filleron T, Wakil G, Rouquette I, Bachaud JM, Leguellec S, Delisle MB, Toulas C, Mazieres J, Cohen-Jonathan Moyal E.
    Clin Lung Cancer; 2012 Jan 15; 13(1):59-67. PubMed ID: 21856239
    [Abstract] [Full Text] [Related]

  • 20. A gene signature combining the tissue expression of three angiogenic factors is a prognostic marker in early-stage non-small cell lung cancer.
    Sanmartín E, Sirera R, Usó M, Blasco A, Gallach S, Figueroa S, Martínez N, Hernando C, Honguero A, Martorell M, Guijarro R, Rosell R, Jantus-Lewintre E, Camps C.
    Ann Surg Oncol; 2014 Feb 15; 21(2):612-20. PubMed ID: 24145997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.